Multiple-Dose Study of VGX-1027 in Healthy Subjects
NCT00760396
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
VGX-1027
Sponsor
VGX Pharmaceuticals, LLC
Collaborators
[object Object]